Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial
Published Online: 2019-01-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Adam M Brufsky•Barry C Lembersky•Charles E Geyer•D Lawrence Wickerham•Edward C McCarron•Eleftherios P Mamounas•Gamini S Soori•Hanna Bandos•James L Wade•Janice M Walshe•Jong-Hyeon Jeong•Louis Fehrenbacher•Mark L Graham•Norman Wolmark•Priya Rastogi•Sandra M Swain•Shaker R Dakhil•Soonmyung Paik•Stephen K Chia•Thomas E Seay
